Structure Therapeutics Inc.
GPCR
Price:
$42.93
Market Cap:
$2.47B
Structure Therapeutics Inc., an international biopharmaceutical company currently in its clinical development phase, is committed to creating and providing groundbreaking oral therapies for various chronic diseases that lack adequate treatment options. The company's primary investigational drug, GSBR-1290, is an orally administered, biased small molecule agonist designed to target the glucagon-like-peptide-1 receptor (GLP-1R). This G-protein-coupled receptor (GPCR) is a recognized and validated therapeutic target for managing both type-2 diabetes mellitus and obesity. Furthermore, Structure Therapeutics is developing other oral small molecule treatments that act on different GPCRs, addressin...[Read more]
Industry
Biotechnology
IPO Date
2023-02-03
Stock Exchange
NASDAQ
Ticker
GPCR
PE Ratio
[-16.26]
ROE
[-15.14%]
Current Ratio
[26.16]
Dividend Yield
[0%]
Enterprise Value
[2.16B]
Dividend History
The PE Ratio as of June 2026 (TTM) for Structure Therapeutics Inc. (GPCR) is -16.26
According to Structure Therapeutics Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -16.26. This represents a change of -853.65% compared to the average of 2.16 of the last 4 quarters.
Structure Therapeutics Inc. (GPCR) Historical PE Ratio (quarterly & annually)
How has GPCR PE Ratio performed in the past?
The mean historical PE Ratio of Structure Therapeutics Inc. over the last ten years is -26.61. The current -16.26 PE Ratio has changed 6.01% with respect to the historical average. Over the past ten years (40 quarters), GPCR's PE Ratio was at its highest in in the December 2025 quarter at 31.19. The PE Ratio was at its lowest in in the December 2022 quarter at -22.96.
Average
-26.61
Median
-21.16
Minimum
-59.82
Maximum
-11.65
Structure Therapeutics Inc. (GPCR) PE Ratio by Quarter and Year
Discovering the peaks and valleys of Structure Therapeutics Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 150.25%
Maximum Annual PE Ratio = -11.65
Minimum Annual Increase = -60.25%
Minimum Annual PE Ratio = -59.82
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -29.16 | 150.25% |
| 2024 | -11.65 | -30.26% |
| 2023 | -16.71 | -9.87% |
| 2022 | -18.54 | -22.04% |
| 2021 | -23.78 | -60.25% |
Structure Therapeutics Inc. (GPCR) Average PE Ratio
How has GPCR PE Ratio performed in the past?
The current PE Ratio of Structure Therapeutics Inc. (GPCR) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-19.17
5-year avg
-19.97
10-year avg
-26.61
Structure Therapeutics Inc. (GPCR) PE Ratio vs. Peers
How is GPCR’s PE Ratio compared to its peers?
Structure Therapeutics Inc.’s PE Ratio is greater than Edgewise Therapeutics, Inc. (-21.20), less than Viridian Therapeutics, Inc. (-4.63), less than uniQure N.V. (-8.28), less than Ocular Therapeutix, Inc. (-6.90), less than Nuvation Bio Inc. (-11.71), less than Galapagos N.V. (3.35), greater than Mesoblast Limited (-22.49), less than Liquidia Corporation (281.04), less than Celldex Therapeutics, Inc. (-7.34), less than AbCellera Biologics Inc. (-11.03),
| Company | PE Ratio | Market cap |
|---|---|---|
| -21.20 | $3.75B | |
| -4.63 | $1.47B | |
| -8.28 | $1.74B | |
| -6.90 | $1.96B | |
| -11.71 | $1.71B | |
| 3.35 | $1.84B | |
| -22.49 | $1.80B | |
| 281.04 | $6.33B | |
| -7.34 | $2.08B | |
| -11.03 | $1.60B |
Build a custom stock screener for Structure Therapeutics Inc. (GPCR) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Structure Therapeutics Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Structure Therapeutics Inc. (GPCR) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Structure Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the PE Ratio?
How can you use the PE Ratio?
What is Structure Therapeutics Inc.'s PE Ratio?
How is the PE Ratio calculated for Structure Therapeutics Inc. (GPCR)?
What is the highest PE Ratio for Structure Therapeutics Inc. (GPCR)?
What is the 3-year average PE Ratio for Structure Therapeutics Inc. (GPCR)?
What is the 5-year average PE Ratio for Structure Therapeutics Inc. (GPCR)?
How does the current PE Ratio for Structure Therapeutics Inc. (GPCR) compare to its historical average?